Fairness opinions › Bankers
Inverness Advisors: healthcare fairness opinions
1 opinions in healthcare transactions, 2014-2014 — 1 to the target board. Each links to the filing and the full summary of analyses.
Opinions
1
2014-2014
Typical DCF discount rate
15.0%–20.0%
median of low / high · n=1
Terminal method
both 1
Median disclosed fee
$0.5M
n=1
Deals
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate |
|---|---|---|---|---|---|---|---|
| 2014-08-27 | Corgenix Medical | Orgentec Diagnostika | Diagnostics / Life Sciences | $16.0M | 8.4x | 1.00x | 15.0%–20.0% |
Segments: Diagnostics / Life Sciences (1)
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.